Cargando…
Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation
The non-nucleoside reverse transcriptase inhibitor (NNRTI) Efavirenz is frequently used in human immunodeficiency virus treatment, but also efficient against cancer in mouse models. Its radiosensitizing effect makes it a promising drug for combination with radiotherapy. The efficacy of Efavirenz com...
Autores principales: | Hecht, Markus, Harrer, Thomas, Körber, Verena, Sarpong, Eric O., Moser, Fabian, Fiebig, Nora, Schwegler, Manuela, Stürzl, Michael, Fietkau, Rainer, Distel, Luitpold V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776903/ https://www.ncbi.nlm.nih.gov/pubmed/29434868 http://dx.doi.org/10.3892/ol.2017.7523 |
Ejemplares similares
-
Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells
por: Hecht, Markus, et al.
Publicado: (2015) -
Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells
por: DU, JIAN, et al.
Publicado: (2012) -
Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells
por: Du, Jian, et al.
Publicado: (2023) -
Comparing the Effects of Intracellular and Extracellular Magnetic Hyperthermia on the Viability of BxPC-3 Cells
por: Hannon, Gary, et al.
Publicado: (2020) -
Intracellular Distributing and Interferon-γ Secretion of Human Interleukin-18 in BxPC-3 Cells
por: Yang, Jin, et al.
Publicado: (2014)